VHL and nonpapillary renal cell carcinoma: Based on these finding, our total CCRCC population was, therefore, stratified into three distinct groups: Group 1, at least one VHL alteration and low VEGF expression; Group 2, at least one VHL alteration and high VEGF expression and Group 3, no VHL alteration regardless of VEGF expression.